[Federal Register Volume 62, Number 156 (Wednesday, August 13, 1997)]
[Notices]
[Pages 43337-43338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-21421]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the National Advisory Council on Drug Abuse, National Institute on
Drug Abuse (NIDA) on September 16-17, 1997, at the National Institutes
of Health, Building 31, 9000 Rockville Pike, Bethesda, MD 20892.
On September 16, from 9 a.m. to 4 p.m., the meeting will be held in
Conference Rooms 9 and 10. In accordance with provisions set forth in
secs. 552b(c)(4), and 552b(c)(6), Title 5, U.S.C. and sec. 10(d) of
Pub. L. 92-463, this portion of the meeting will be closed to the
public for the review, discussion, and evaluation of grant
applications. These applications and the
[[Page 43338]]
discussions could reveal confidential trade secrets or commercial
property such as patentable material and personal information
concerning individuals associated with the applications, disclosure of
which would constitute a clearly unwarranted invasion of personal
privacy.
On September 17, from 9 a.m. to 5 p.m., the meeting will be held in
Conference Room 10. This portion of the meeting will be open to the
public for announcements and reports of administrative, legislative,
and program developments in the drug abuse field. Attendance by the
public will be limited to space available.
A summary of the meeting and a roster of committee members may be
obtained from Ms. Camilla L. Holland, NIDA Committee Management
Officer, National Institutes of Health, Parklawn Building, Room 10-42,
5600 Fishers Lane, Rockville, Maryland 20857, (301/443-2755).
Substantive program information may be obtained from Dr. Teresa
Levitin, Room 10-42, Parklawn Building, 5600 Fishers Lane, Rockville,
Maryland 20857, (301/443-2755).
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
contact Dr. Levitin in advance of the meeting.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Research Scientist Development and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for
Research Training; 93.279, Drug Abuse Research Programs)
Dated: August 7, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-21421 Filed 8-12-97; 8:45 am]
BILLING CODE 4140-01-M
